The British Journal of Cardiology

JUNE 11, 2024

Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). Cardiovascular consultation had been requested for all of the patients based on their primary clinical examination, vital signs, and electrocardiogram (ECG).

COVID-19 40

COVID-19 Cardiovascular Disease Angina Chest Pain 40

DAIC

FEBRUARY 29, 2024

Clinical and Investigative Horizons (Session 410) Sunday, April 7 4:30 – 5:45 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Dr. Smith's ECG Blog

FEBRUARY 8, 2015

Be ready to give nitroprusside if the blood pressure does go unacceptably high [ unopposed alpha in possible cocaine overdose is an overblown concern: see discussion below] Fourth , if it is AV nodal re-entrant tachycardia, sometimes a dose of 18 mg of adenosine is necessary. Marcus, G. Only beta-2 blockade (e.g., Hollander, J.

Tachycardia 52

Tachycardia Chest Pain Pharmacology Myocardial Infarction 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Risk factors such as smoking, chronic kidney disease, and aging can contribute to plaque formation. The gradual loss of elasticity in arterial walls and the presence of other risk factors, such as high blood pressure and diabetes, contribute to the increased risk of cardiovascular disease (CVD) observed in aging populations.

Risk Factors 40

Risk Factors Blood Pressure Chest Pain Plaque 40

Wellnest

DECEMBER 31, 2023

Risk of Cardiovascular Disease by COVID-19 Can COVID-19 damage the heart? Yes, COVID-19, primarily a respiratory disease, can affect the heart. Additionally, coronavirus infection affects blood vessels, leading to inflammation, clotting, and potential compromise of blood flow to the heart. Risk posed by JN.1

COVID-19 52

COVID-19 Heart Attack Heart attacks Exercise 52

DAIC

APRIL 1, 2024

“We are witnessing a paradigm shift in how valvular heart diseases are diagnosed and treated,” said Partho Sengupta , Henry Rutgers Professor of Cardiology and chief of the Division of Cardiovascular Disease and Hypertension at Rutgers Robert Wood Johnson Medical School.

Technology 105

Technology Heart Disease Innovation Ultrasound 105

Heart BMJ

JANUARY 10, 2024

An adult patient presented with palpitations, chest pain and reduced exertional capacity for 3 years. There was no family history of cardiovascular disease or sudden cardiac death. Blood pressure was elevated.

Sudden Cardiac Death 40

Sudden Cardiac Death Chest Pain Blood Pressure Laboratory 40